$0.84 Earnings Per Share Expected for Xylem Inc (NYSE:XYL) This Quarter

Equities research analysts expect Xylem Inc (NYSE:XYL) to announce earnings per share (EPS) of $0.84 for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Xylem’s earnings. The lowest EPS estimate is $0.81 and the highest is $0.90. Xylem reported earnings of $0.77 per share during the same quarter last year, which indicates a positive year over year growth rate of 9.1%. The business is scheduled to issue its next earnings report on Tuesday, October 29th.

According to Zacks, analysts expect that Xylem will report full-year earnings of $3.17 per share for the current fiscal year, with EPS estimates ranging from $3.13 to $3.20. For the next year, analysts expect that the company will post earnings of $3.64 per share, with EPS estimates ranging from $3.47 to $3.75. Zacks’ earnings per share calculations are an average based on a survey of sell-side research analysts that that provide coverage for Xylem.

Xylem (NYSE:XYL) last released its quarterly earnings results on Thursday, August 1st. The industrial products company reported $0.79 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.79. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.35 billion. Xylem had a return on equity of 19.23% and a net margin of 10.90%. The firm’s revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.73 EPS.

Several brokerages recently weighed in on XYL. Zacks Investment Research upgraded Xylem from a “sell” rating to a “hold” rating and set a $83.00 target price for the company in a research note on Saturday, September 14th. ValuEngine downgraded Xylem from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Credit Suisse Group downgraded Xylem from an “outperform” rating to a “neutral” rating in a research note on Friday, August 2nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $79.17.

In other Xylem news, insider Colin R. Sabol sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, July 1st. The stock was sold at an average price of $84.28, for a total value of $337,120.00. Following the completion of the transaction, the insider now owns 35,781 shares of the company’s stock, valued at approximately $3,015,622.68. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Tomas Brannemo sold 6,683 shares of the company’s stock in a transaction that occurred on Monday, June 24th. The shares were sold at an average price of $81.90, for a total value of $547,337.70. Following the completion of the transaction, the insider now directly owns 20,161 shares of the company’s stock, valued at approximately $1,651,185.90. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 28,027 shares of company stock valued at $2,252,433. 0.85% of the stock is owned by corporate insiders.

Institutional investors have recently bought and sold shares of the business. Rothschild & Co Wealth Management UK Ltd acquired a new position in shares of Xylem in the 2nd quarter worth approximately $293,000. River & Mercantile Asset Management LLP acquired a new position in shares of Xylem in the 2nd quarter worth approximately $921,000. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its holdings in shares of Xylem by 4.7% in the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 614,149 shares of the industrial products company’s stock worth $51,367,000 after buying an additional 27,492 shares in the last quarter. EP Wealth Advisors LLC acquired a new position in shares of Xylem in the 2nd quarter worth approximately $290,000. Finally, Atria Investments LLC raised its holdings in shares of Xylem by 99.3% in the 2nd quarter. Atria Investments LLC now owns 6,167 shares of the industrial products company’s stock worth $466,000 after buying an additional 3,072 shares in the last quarter. 84.49% of the stock is owned by hedge funds and other institutional investors.

XYL opened at $77.95 on Tuesday. The company has a market cap of $14.11 billion, a PE ratio of 27.07, a price-to-earnings-growth ratio of 1.49 and a beta of 1.20. The stock has a 50-day moving average of $76.78 and a 200-day moving average of $78.90. Xylem has a 52-week low of $60.65 and a 52-week high of $85.39. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.08 and a current ratio of 1.47.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 26th. Investors of record on Thursday, August 29th will be paid a dividend of $0.24 per share. The ex-dividend date of this dividend is Wednesday, August 28th. This represents a $0.96 annualized dividend and a yield of 1.23%. Xylem’s payout ratio is 33.33%.

About Xylem

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Further Reading: What is a good rate of return for a mutual fund?

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.